S
Steven Newman
Researcher at Northwestern University
Publications - 17
Citations - 2810
Steven Newman is an academic researcher from Northwestern University. The author has contributed to research in topics: Performance status & TheraSphere. The author has an hindex of 13, co-authored 17 publications receiving 2617 citations.
Papers
More filters
Journal ArticleDOI
Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes.
Riad Salem,Robert J. Lewandowski,Mary F. Mulcahy,Ahsun Riaz,Robert K. Ryu,S.M. Ibrahim,Bassel Atassi,Talia Baker,Vanessa L. Gates,Frank H. Miller,Kent T. Sato,E. D. Wang,Ramona Gupta,Al B. Benson,Steven Newman,Reed A. Omary,Michael Abecassis,Laura Kulik +17 more
TL;DR: Clinical outcomes of patients treated with intra-arterial yttrium-90 microspheres (Y90) can be used to design future Y90 trials and to describe Y90 as a potential treatment option for patients with HCC.
Journal ArticleDOI
Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma.
Riad Salem,Robert J. Lewandowski,Laura Kulik,Edward Wang,Ahsun Riaz,Robert K. Ryu,Kent T. Sato,Ramona Gupta,Paul Nikolaidis,Frank H. Miller,Vahid Yaghmai,S.M. Ibrahim,Seanthan Senthilnathan,Talia Baker,Vanessa L. Gates,Bassel Atassi,Steven Newman,Khairuddin Memon,Richard Chen,Robert L. Vogelzang,Albert A. Nemcek,Scott A. Resnick,Howard B. Chrisman,James C. Carr,Reed A. Omary,Michael Abecassis,Al B. Benson,Mary F. Mulcahy +27 more
TL;DR: Post hoc analyses of sample size indicated that a randomized study with > 1000 patients would be required to establish equivalence of survival times between patients treated with these two therapies.
Journal ArticleDOI
Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival.
Kent T. Sato,Robert J. Lewandowski,Mary F. Mulcahy,Bassel Atassi,Robert K. Ryu,Vanessa L. Gates,Albert A. Nemcek,Omar Barakat,Al B. Benson,Robert Mandal,Mark S. Talamonti,Ching Yee O. Wong,Frank H. Miller,Steven Newman,John M. Shaw,Kenneth G. Thurston,Reed A. Omary,Riad Salem +17 more
TL;DR: Y hepatic treatments are well tolerated with acceptable toxicities; tumor response and median survival are promising.
Journal ArticleDOI
Alpha-Fetoprotein Response After Locoregional Therapy for Hepatocellular Carcinoma: Oncologic Marker of Radiologic Response, Progression, and Survival
Ahsun Riaz,Robert K. Ryu,Laura Kulik,Mary F. Mulcahy,Robert J. Lewandowski,Jeet Minocha,S.M. Ibrahim,Kent T. Sato,Talia Baker,Frank H. Miller,Steven Newman,Reed A. Omary,Michael Abecassis,Al B. Benson,Riad Salem +14 more
TL;DR: The data presented support the use of AFP response seen after locoregional therapy as an ancillary method of assessing tumor response and survival, as well as an early objective screening tool for progression by imaging.
Journal ArticleDOI
Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study.
S.M. Ibrahim,Mary F. Mulcahy,Robert J. Lewandowski,Kent T. Sato,Robert K. Ryu,Elizabeth J. Masterson,Steven Newman,Al B. Benson,Reed A. Omary,Riad Salem +9 more
TL;DR: The objective of this report was to present data from an open‐label cohort study in which patients with intrahepatic cholangiocarcinoma (ICC) underwent radioembolization with yttrium‐90 (90Y) microspheres.